Characterization of ATM gene mutations in 66 ataxia telangiectasia families - PubMed (original) (raw)
M Platzer, A Rosenthal, T Dörk, R Bendix, B Skawran, M Stuhrmann, R D Wegner, K Sperling, S Banin, Y Shiloh, A Baumer, U Bernthaler, H Sennefelder, M Brohm, B H Weber, D Schindler
Affiliations
- PMID: 9887333
- DOI: 10.1093/hmg/8.1.69
Characterization of ATM gene mutations in 66 ataxia telangiectasia families
N Sandoval et al. Hum Mol Genet. 1999 Jan.
Abstract
Ataxia telangiectasia (AT) is an autosomal recessive disease characterized by neurological and immunological symptoms, radiosensitivity and cancer predisposition. The gene mutated in AT, designated the ATM gene, encodes a large protein kinase with a PI-3 kinase-related domain. In this study, we investigated the mutational spectrum of the ATM gene in a cohort of AT patients living in Germany. We amplified and sequenced all 66 exons and the flanking untranslated regions from genomic DNA of 66 unrelated AT patients. We identified 46 different ATM mutations and 26 sequence polymorphisms and variants scattered throughout the gene. A total of 34 mutations have not been described in other populations. Seven mutations occurred in more than one family, but none of these accounted for more than five alleles in our patient group. The majority of the mutations were truncating, confirming that the absence of full-length ATM protein is the most common molecular basis of AT. Transcript analyses demonstrated single exon skipping as the consequence of most splice site substitutions, but a more complex pattern was observed for two mutations. Immunoblot studies of cell lines carrying ATM missense substitutions or in-frame deletions detected residual ATM protein in four cases. One of these mutations, a valine deletion proximal to the kinase domain, resulted in ATM protein levels >20% of normal in an AT lymphoblastoid cell line. In summary, our results survey and characterize a plethora of variations in the ATM gene identified by exon scanning sequencing and indicate a high diversity of mutations giving rise to AT in a non-isolated population.
Similar articles
- Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.
Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengüt S, Tolun A, Chessa L, Sanal O, Bernatowska E, Gatti RA, Concannon P. Teraoka SN, et al. Am J Hum Genet. 1999 Jun;64(6):1617-31. doi: 10.1086/302418. Am J Hum Genet. 1999. PMID: 10330348 Free PMC article. - Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene.
Platzer M, Rotman G, Bauer D, Uziel T, Savitsky K, Bar-Shira A, Gilad S, Shiloh Y, Rosenthal A. Platzer M, et al. Genome Res. 1997 Jun;7(6):592-605. doi: 10.1101/gr.7.6.592. Genome Res. 1997. PMID: 9199932 - Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia.
Concannon P, Gatti RA. Concannon P, et al. Hum Mutat. 1997;10(2):100-7. doi: 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O. Hum Mutat. 1997. PMID: 9259193 Review. - Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J. Boultwood J. J Clin Pathol. 2001 Jul;54(7):512-6. doi: 10.1136/jcp.54.7.512. J Clin Pathol. 2001. PMID: 11429421 Free PMC article. Review.
Cited by
- Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.
Richardson ME, Holdren M, Brannan T, de la Hoya M, Spurdle AB, Tavtigian SV, Young CC, Zec L, Hiraki S, Anderson MJ, Walker LC, McNulty S, Turnbull C, Tischkowitz M, Schon K, Slavin T, Foulkes WD, Cline M, Monteiro AN, Pesaran T, Couch FJ. Richardson ME, et al. medRxiv [Preprint]. 2024 May 29:2024.05.28.24307502. doi: 10.1101/2024.05.28.24307502. medRxiv. 2024. PMID: 38854136 Free PMC article. Updated. Preprint. - Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.
van der Merwe NC, Buccimazza I, Rossouw B, Araujo M, Ntaita KS, Schoeman M, Vorster K, Napo K, Kotze MJ, Oosthuizen J. van der Merwe NC, et al. Breast Cancer Res Treat. 2024 Sep;207(2):331-342. doi: 10.1007/s10549-024-07362-2. Epub 2024 May 30. Breast Cancer Res Treat. 2024. PMID: 38814507 Free PMC article. - Evaluation of Ataxia-Telangiectasia Mutated IVS10 Mutation in Breast Cancer Along with Clinicopathological Parameters.
Ahuja S, Aneja H, Yadav AK, Ranga S, Chintamani, Paul J. Ahuja S, et al. J Midlife Health. 2023 Oct-Dec;14(4):272-279. doi: 10.4103/jmh.jmh_71_23. Epub 2024 Feb 23. J Midlife Health. 2023. PMID: 38504739 Free PMC article. - The clinical spectrum of ataxia telangiectasia in a cohort in Sweden.
Lindahl H, Svensson E, Danielsson A, Puschmann A, Svenningson P, Tesi B, Paucar M. Lindahl H, et al. Heliyon. 2024 Feb 15;10(4):e26073. doi: 10.1016/j.heliyon.2024.e26073. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38404774 Free PMC article. - Effects of Ataxia-Telangiectasia Mutated Variants on Radionecrosis and Local Control After Stereotactic Radiation Surgery for Non-Small Cell Lung Cancer Brain Metastases.
Floyd W, Carpenter D, Vaios E, Shenker R, Hendrickson P, Adamson JD, Giles WM, Wang C, Allen K, Mullikin T, Floyd SR, Kirkpatrick JP, Green M, Reitman ZJ. Floyd W, et al. Adv Radiat Oncol. 2023 Jul 22;9(1):101320. doi: 10.1016/j.adro.2023.101320. eCollection 2024 Jan. Adv Radiat Oncol. 2023. PMID: 38260227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous